Of note, IL-6 promotes the survival and proliferation of tumor cells and attenuates the antitumor ability of tumor-infiltrating immune cells through the IL-6/JAK/STAT3 signaling pathway in the TME[62]. The gene discussed is STAT3; the disease is neoplasm.